For many patients, this can lead to: Loose or sagging skin Hollow cheeks or temples Increased fine lines and wrinkles Crepey skin texture Loss of facial definition Deflated appearance in areas like the breasts or buttocks These changes are not caused by the medication itself as much as they are the result of rapid weight loss
However, evidence points to the safety of this approach in patients on GLP-1 RAs
For selected patients, yes
21 While increasing protein intake is fundamental for muscle preservation, it works most effectively when combined with the right type of exercise
While GLP-1 receptor agonists (such as semaglutide and liraglutide) have demonstrated significant benefits in diabetes management, weight reduction, and cardiovascular outcomes in clinical trials, enhancing physiological GLP-1 through dietary and lifestyle modifications represents a foundational approach
GLP-1 medications are a distinct pharmaceutical intervention